- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Contacts
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Replacing the Animal Component in SerumEvaluating Raw Materials for Inclusion in Optimized Hybridoma Media
September 2, 2001
Pharmaceutical Technology, Pharmaceutical Technology-09-02-2001, Volume 25, Issue 9
With the scarcity of CGMP facilities spurring a production crisis, manufacturers need to optimize their processes and formulations for individual hybridoma cell lines and production systems.
Related Content: